KMC Implementation Research for Accelerating Scale-up in Oromia Region, Ethiopia (KMC-Oromia)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03419416|
Recruitment Status : Completed
First Posted : February 5, 2018
Last Update Posted : July 16, 2019
|Condition or disease||Intervention/treatment|
|Low Birth-weight||Other: Kangaroo mother care (KMC)|
To achieve the objective summarized above, the investigators will engage in an iterative process using program learning and quantitative data to continuously improve models in order to enhance uptake of KMC in two phases.
In phase 1, the model will undergo an iterative process whereby every three months, the investigators will analyze the data collected and improve the model until it is reached at a model that achieves effective KMC coverage of at least 80%.
In phase 2, we will scale the successful model to all selected facilities.
The investigators' primary outcomes will be effective coverage of KMC at 7 days of age, and effective coverage of KMC at 7 days after discharge from the facility. Effective coverage will be defined as adoption of skin to skin care for at 8 least hours and exclusive breastfeeding in the 24 hours prior to assessment
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||700 participants|
|Target Follow-Up Duration:||28 Days|
|Official Title:||KMC Implementation Research for Accelerating Scale-up in Oromia Region, Ethiopia|
|Actual Study Start Date :||June 24, 2017|
|Actual Primary Completion Date :||June 30, 2019|
|Actual Study Completion Date :||June 30, 2019|
- Other: Kangaroo mother care (KMC)
Skin to skin contact of newborns with mothers and exclusive breast feeding
- Effective coverage of KMC at 7 days of age. [ Time Frame: Seven days of age ]Effective coverage will be defined as adoption of skin-to-skin care for at least 8 hours and exclusive breastfeeding in the 24 hours prior to assessment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03419416
|Tirunesh Beijing Hospital|
|Akaki, Addis Ababa, Ethiopia|
|Adami Tulu, Oromia, Ethiopia|
|Study Director:||Rajiv Bahl, MD, PhD||World Health Organization|